Bringing the fundamentals into focus…
Back to Ascendis Pharma A/S
How Ascendis Pharma A/S stacks up
ASND · against 126 other Healthcare companies of similar size
Profitability
15/ 100
Near the bottom of its peers.
Ranked #119 of 127 · scores higher than 6% of peers
Bars: peers in each 10-point band of the profitability score6 peers with a profitability score of 10–19, including ASND · Click a bar to see the companies
Why profitability scores 15?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
- a lower return on invested capital: weaker than 97% of peers. Return on invested capital: -300.9% vs peer median 4.7%
- a lower return on assets: weaker than 79% of peers. Return on assets: -17.5% vs peer median 1.7%
- a thinner operating margin: weaker than 77% of peers. Operating margin: -18.9% vs peer median 7.1%
Metric by metric
Position: dot = ASND, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ASND | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 122 reported | -300.9% | 10.5% | 2% | 33% | |
| Operating marginHigher is better · 125 reported | -18.9% | 15.2% | 12% | 33% | |
| Return on assetsHigher is better · 124 reported | -17.5% | 6.2% | 10% | 33% | |
| Return on equityHigher is better · 120 reported | 118.8% | 11.4% | 98% | Context only | |
| Gross marginHigher is better · 131 reported | 91.3% | 58.9% | 92% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ASND| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 115 | 13.7B USD | 22 | 45 | |
| 116 | 8.4B USD | 21 | 28 | |
| 116 | 9.2B USD | 21 | 39 | |
| 116 | 9.3B USD | 21 | 29 | |
| 119 | 16.5B USD | 15 | 37 | |
| 120 | 23.5B USD | 14 | 27 | |
| 120 | 22.8B USD | 14 | 38 | |
| 122 | 10.5B USD | 12 | 56 | |
| 123 | 14.5B USD | 10 | 30 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score